Respiratory syncytial virus infections in infants affected by primary immunodeficiency

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Lanari, Marcello ^a   Vandini, Silvia ^b   Capretti, Maria Grazia ^b   Lazzarotto, Tiziana ^b   Faldella, Giacomo ^b  

^a Imola Hospital   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PALIVIZUMAB; ANTIVIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; CELLULAR IMMUNITY; CHILD HOSPITALIZATION; CHRONIC LUNG DISEASE; CONGENITAL HEART DISEASE; DISEASE COURSE; ENVIRONMENTAL PROPHYLAXIS; ENVIRONMENTAL PROTECTION; HAND WASHING; HIGH RISK INFANT; HOSPITALIZED INFANT; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; INFANCY; INFANT; INFECTION PREVENTION; LOWER RESPIRATORY TRACT INFECTION; NONHUMAN; PREMATURITY; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SEASON; VIRUS REPLICATION; VIRUS SHEDDING; CHEMOPROPHYLAXIS; COMPLICATION; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; NEWBORN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

ANTIVIRAL AGENTS; CHEMOPREVENTION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INFANT, NEWBORN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 84904152605     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/850831     Document Type: Article

References (68)

1. Simoes E. A. F., Respiratory syncytial virus infection. The Lancet 1999 354 9181 847 852 10.1016/S0140-6736(99)80040-3 2-s2.0-0033523417 (Pubitemid 29415599)
2. Nair H., Verma V. R., Theodoratou E., Zgaga L., Huda T., Simões E. A., Wright P. F., Rudan I., Campbell H., An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children. BMC Public Health 2011 11 supplement 3, article S30 10.1186/1471-2458-11-S3-S30 2-s2.0-79954567948
3. Hall C. B., Weinberg G. A., Iwane M. K., Blumkin A. K., Edwards K. M., Staat M. A., Auinger P., Griffin M. R., Poehling K. A., Erdman D., Grijalva C. G., Zhu Y., Szilagyi P., The Burden of respiratory syncytial virus infection in young children. The New England Journal of Medicine 2009 360 6 588 598 10.1056/NEJMoa0804877 2-s2.0-59749095702
4. Paramore L. C., Ciuryla V., Ciesla G., Liu L., Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. PharmacoEconomics 2004 22 5 275 284 10.2165/00019053-200422050-00001 2-s2.0-2142657849 (Pubitemid 38553698)
5. Blanken M. O., Rovers M. M., Molenaar J. M., Winkler-Seinstra P. L., Meijer A., Kimpen J. L. L., Bont L., Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. The New England Journal of Medicine 2013 368 19 1791 1799 10.1056/NEJMoa1211917 2-s2.0-84877600733
6. Thompson W. W., Shay D. K., Weintraub E., Brammer L., Cox N., Anderson L. J., Fukuda K., Mortality associated with influenza and respiratory syncytial virus in the United States. The Journal of the American Medical Association 2003 289 2 179 186 10.1001/jama.289.2.179 2-s2.0-0037425564 (Pubitemid 36068705)
7. Asner S., Stephens D., Pedulla P., Richardson S. E., Robinson J., Allen U., Risk factors and outcomes for respiratory syncytial virus-related infections in immunocompromised children. Pediatric Infectious Disease Journal 2013 32 10 1073 1076 10.1097/INF.0b013e31829dff4d 2-s2.0-84878370910
8. Choi J. H., Choi E. H., Kang H. J., Park K. D., Park S. S., Shin H. Y., Lee H. J., Ahn H. S., Respiratory viral infections after hematopoietic stem cell transplantation in children. Journal of Korean Medical Science 2013 28 1 36 41 10.3346/jkms.2013.28.1.36 2-s2.0-84874772808
9. Gaboli M., de la Cruz O. A., de Agüero M. I., Moreno-Galdó A., Pérez G. P., de Querol M. S., Use of palivizumab in infants and young children with severe respiratory disease: a delphi study. Pediatric Pulmonology 2014 49 5 490 502 10.1002/ppul.22826
10. Kim Y. J., Boeckh M., Englund J. A., Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Seminars in Respiratory and Critical Care Medicine 2007 28 2 222 242 10.1055/s-2007-976494 2-s2.0-34247633653 (Pubitemid 46676916)
11. Resch B., Manzoni P., Lanari M., Severe respiratory syncytial virus (RSV) infection in infants with neuromuscular diseases and immune deficiency syndromes. Paediatric Respiratory Reviews 2009 10 3 148 153 10.1016/j.prrv.2009. 06.003 2-s2.0-67849084667
12. Thorburn K., Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Archives of Disease in Childhood 2009 94 2 99 103 10.1136/adc.2008.139188 2-s2.0-59649115078
13. Sommer C., Resch B., Simões E. A., Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiology Journal 2011 5 2 144 154 10.2174/1874285801105010144 2-s2.0-84855755161
14. Martinello R. A., Chen M. D., Weibel C., Kahn J. S., Correlation between respiratory syncytial virus genotype and severity of illness. Journal of Infectious Diseases 2002 186 6 839 842 10.1086/342414 2-s2.0-0037105638 (Pubitemid 35013438)
15. Gilca R., de Serres G., Tremblay M., Vachon M., Leblanc E., Bergeron M. G., Déry P., Boivin G., Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons. Journal of Infectious Diseases 2006 193 1 54 58 10.1086/498526 2-s2.0-29744445107 (Pubitemid 43032499)
16. Vandini S., Corvaglia L., Alessandroni R., Aquilano G., Marsico C., Spinelli M., Lanari M., Faldella G., Respiratory syncytial virus infection in infants and correlation with meteorological factors and air pollutants. Italian Journal of Pediatrics 2013 39 1, article 1 10.1186/1824-7288-39-1 2-s2.0-84872158974
17. Meerhoff T. J., Paget J. W., Kimpen J. L., Schellevis F., Variation of respiratory syncytial virus and the relation with meteorological factors in different winter seasons. Pediatric Infectious Disease Journal 2009 28 10 860 866 10.1097/INF.0b013e3181a3e949 2-s2.0-70349687749
18. Noyola D. E., Mandeville P. B., Effect of climatological factors on respiratory syncytial virus epidemics. Epidemiology and Infection 2008 136 10 1328 1332 10.1017/S0950268807000143 2-s2.0-52249104644
19. Garcia-Barreno B., Palomo C., Penas C., Delgado T., Perez-Brena P., Melero J. A., Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. Journal of Virology 1989 63 2 925 932 2-s2.0-0024505373 (Pubitemid 19057262)
20. + T cell activation by dendritic cells. PLoS ONE 2010 5 11 e15017 10.1371/journal.pone.0015017 2-s2.0-78649743343
21. Groothuis J. R., Hoopes J. M., Jessie V. G. H., Prevention of serious respiratory syncytial virus-related illness. I: disease pathogenesis and early attempts at prevention. Advances in Therapy 2011 28 2 91 109 10.1007/s12325-010-0100-z 2-s2.0-79952539202
22. Ohuma E. O., Okiro E. A., Ochola R., Sande C. J., Cane P. A., Medley G. F., Bottomley C., Nokes D. J., The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and disease. American Journal of Epidemiology 2012 176 9 794 802 10.1093/aje/kws257 2-s2.0-84868037151
23. Piedra P. A., Jewell A. M., Cron S. G., Atmar R. L., Glezen W. P., Correlates of immunity to respiratory syncytial virus (RSV) associated- hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies. Vaccine 2003 21 24 3479 3482 10.1016/S0264-410X(03) 00355-4 2-s2.0-0038384092 (Pubitemid 36792107)
24. Mejías A., Chávez-Bueno S., Ríos A. M., Aten M. F., Raynor B., Peromingo E., Soni P., Olsen K. D., Kiener P. A., Gómez A. M., Jafri H. S., Ramilo O., Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus Potency. Antimicrobial Agents and Chemotherapy 2005 49 11 4700 4707 10.1128/AAC.49.11.4700-4707.2005 2-s2.0-27644485407 (Pubitemid 41552602)
25. Domachowske J. B., Rosenberg H. F., Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clinical Microbiology Reviews 1999 12 2 298 309 2-s2.0-0032890867 (Pubitemid 29196855)
26. + T cell balance during respiratory syncytial virus infections. Journal of Immunology 2010 185 11 6489 6498 10.4049/jimmunol.1002645 2-s2.0-78650651909
27. McIntosh K., Masters H. B., Orr I., Chao R. K., Barkin R. M., The immunologic response to infection with respiratory syncytial virus in infants. Journal of Infectious Diseases 1978 138 1 24 32 10.1093/infdis/138.1.24 2-s2.0-0018098659 (Pubitemid 8399824)
28. McIntosh K., McQuillin J., Gardner P. S., Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection. Infection and Immunity 1979 23 2 276 281 2-s2.0-0018419277 (Pubitemid 9119826)
29. Graham B. S., Henderson G. S., Tang Y. W., Lu X., Neuzil K. M., Colley D. G., Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. The Journal of Immunology 1993 151 4 2032 2040 2-s2.0-0027283977 (Pubitemid 23235675)
30. Law B. J., Wang E. E., MacDonald N., McDonald J., Dobson S., Boucher F., Langley J., Robinson J., Mitchell I., Stephens D., Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database. Pediatrics 1997 99 3, article E7 2-s2.0-0031083736
31. Christiaansen A. F., Knudson C. J., Weiss K. A., Varga S. M., The CD4 T cell response to respiratory syncytial virus infection. Immunologic Research 2014 10.1007/s12026-014-8540-1
32. You D., Marr N., Saravia J., Shrestha B., Lee G. I., Turvey S. E., IL-4Ra on CD4+ T cells plays a pathogenic role in respiratory syncytial virus reinfection in mice infected initially as neonates. Journal of Leukocyte Biology 2013 93 6 933 942
33. Fulton R. B., Meyerholz D. K., Varga S. M., Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. Journal of Immunology 2010 185 4 2382 2392 10.4049/jimmunol.1000423 2-s2.0-77956913784
34. + natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection. Journal of Virology 2010 84 17 8790 8798 10.1128/JVI.00796-10 2-s2.0-77956635170
35. + T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection. The Journal of Immunology 2011 187 6 3145 3154 10.4049/jimmunol.1100764 2-s2.0-80053085640
36. Chin J., Magoffin R. L., Shearer L. A., Schieble J. H., Lennette E. H., Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. American Journal of Epidemiology 1969 89 4 449 463 2-s2.0-0014495164
37. Castilow E. M., Varga S. M., Overcoming T-cell-mediated immunopathology to achieve safe respiratory syncytial virus vaccination. Future Virology 2008 3 5 445 454 10.2217/17460794.3.5.445 2-s2.0-55849152459
38. Kapikian A. Z., Mitchell R. H., Chanock R. M., Shvedoff R. A., Stewart C. E., An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. The American Journal of Epidemiology 1969 89 4 405 421 2-s2.0-0014493282
39. Kim H. W., Canchola J. G., Brandt C. D., Pyles G., Chanock R. M., Jensen K., Parrott R. H., Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology 1969 89 4 422 434 2-s2.0-0014495251
40. Murata Y., Respiratory syncytial virus vaccine development. Clinics in Laboratory Medicine 2009 29 4 725 739 10.1016/j.cll.2009.07.004 2-s2.0-70350515701
41. Alwan W. H., Record F. M., Openshaw P. J. M., CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells. Clinical and Experimental Immunology 1992 88 3 527 536 2-s2.0-0026780401
42. Tang Y., Graham B. S., T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice. The Journal of Clinical Investigation 1997 99 9 2183 2191 10.1172/JCI119391 2-s2.0-0031010847 (Pubitemid 27203774)
43. Crooks B. N. A., Taylor C. E., Turner A. J. L., Osman H. K. E., Abinun M., Flood T. J., Cant A. J., Respiratory viral infections in primary immune deficiencies: significance and relevance to clinical outcome in a single BMT unit. Bone Marrow Transplantation 2000 26 10 1097 1102 10.1038/sj.bmt.1702656 2-s2.0-0033693177
44. Al-Herz W., Notarangelo L. D., Classification of primary immunodeficiency disorders: one-fits-all does not help anymore. Clinical Immunology 2012 144 1 24 25 10.1016/j.clim.2012.05.003 2-s2.0-84861555765
45. Baker M. W., Grossman W. J., Laessig R. H., Hoffman G. L., Brokopp C. D., Kurtycz D. F., Cogley M. F., Litsheim T. J., Katcher M. L., Routes J. M., Development of a routine newborn screening protocol for severe combined immunodeficiency. Journal of Allergy and Clinical Immunology 2009 124 3 522 527 10.1016/j.jaci.2009.04.007 2-s2.0-69349101950
46. Notarangelo L. D., Primary immunodeficiencies. Journal of Allergy and Clinical Immunology 2010 125 2, supplement 2 S182 S194 10.1016/j.jaci.2009.07. 053 2-s2.0-76749147849
47. Al-Herz W., Moussa M. A. A., Survival and predictors of death among primary immunodeficient patients: a registry-based study. Journal of Clinical Immunology 2012 32 3 467 473 10.1007/s10875-011-9636-1 2-s2.0-84861481569
48. Lo M. S., Lee G. M., Gunawardane N., Burchett S. K., Lachenauer C. S., Lehmann L. E., The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy. Pediatric Transplantation 2013 17 2 133 143 10.1111/petr.12022 2-s2.0-84874485008
49. Shachor-Meyouhas Y., Zaidman I., Kra-Oz Z., Arad-Cohen N., Kassis I., Detection, control, and management of a respiratory syncytial virus outbreak in a pediatric hematology-oncology department. Journal of Pediatric Hematology/Oncology 2013 35 2 124 128 10.1097/MPH.0b013e3182756edc 2-s2.0-84874466500
50. Mendoz S. M. C., Ruiz-Contreras J., Vivanco J. L., Fernández- Carrión F., Fernández M. B., Ramos J. T., Otero J. R., Folgueira D., Respiratory virus infections in children with cancer or HIV infection. Journal of Pediatric Hematology/Oncology 2006 28 3 154 159 10.1097/01.mph. 0000210061.96075.8e (Pubitemid 43791812)
51. Moyes J., Cohen C., Pretorius M., Groome M., von Gottberg A., Wolter N., Walaza S., Haffejee S., Chhagan M., Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010-2011. The Journal of Infectious Diseases 2013 208 supplement 3 S217 S226 10.1093/infdis/jit479
52. Hall C. B., Powell K. R., MacDonald N. E., Gala C. L., Menegus M. E., Suffin S. C., Cohen H. J., Respiratory syncytial viral infection in children with compromised immune function. The New England Journal of Medicine 1986 315 2 77 81 10.1056/NEJM198607103150201 2-s2.0-0022589560 (Pubitemid 16093208)
53. Navas L., Wang E., de Carvalho V., Robinson J., Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Journal of Pediatrics 1992 121 3 348 354 10.1016/S0022- 3476(05)90000-0 2-s2.0-0026744974
54. Wang E. E., Law B. J., Stephens D., Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. The Journal of Pediatrics 1995 126 2 212 219 10.1016/S0022-3476(95)70547-3 2-s2.0-0028984727
55. Murphy M., Lempert M. J., Epstein L. B., Decreased level of T cell receptor expression by Down syndrome (trisomy 21) thymocytes. American Journal of Medical Genetics 1990 37 supplement S7 234 237 2-s2.0-0025607862 10.1002/ajmg.1320370747
56. Murphy M., Hyun W., Hunte B., Levine A. D., Epstein L. B., A role for tumor necrosis factor-and interferon- γ in the regulation of interleukin-4-induced human thymocyte proliferation in vitro. Heightened sensitivity in the Down syndrome (trisomy 21) thymus. Pediatric Research 1992 32 3 269 276 10.1203/00006450-199209000-00004 2-s2.0-0026783986
57. De Hingh Y. C. M., Van Der Vossen P. W., Gemen E. F. A., Mulder A. B., Hop W. C. J., Brus F., De Vries E., Intrinsic abnormalities of lymphocyte counts in children with down syndrome. Journal of Pediatrics 2005 147 6 744 747 10.1016/j.jpeds.2005.07.022 2-s2.0-28844486209 (Pubitemid 41774828)
58. Bloemers B. L. P., van Furth A. M., Weijerman M. E., Gemke R. J. B. J., Broers C. J. M., van den Ende K., Kimpen J. L. L., Strengers J. L. M., Bont L. J., Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis-a prospective birth-cohort study. Pediatrics 2007 120 4 e1076 e1081 10.1542/peds.2007-0788 2-s2.0-35148824990 (Pubitemid 47549555)
59. Blanchard S. S., Gerrek M., Siegel C., Czinn S. J., Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation: case report and discussion regarding need of routine prophylaxis. Pediatric Transplantation 2006 10 7 826 829 10.1111/j.1399-3046. 2006.00583.x 2-s2.0-33749561630 (Pubitemid 44536410)
60. The IMpact-RSV Study Group, Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998 102 3, part 1 531 537 10.1542/peds.102.3.531 2-s2.0-0031683919 (Pubitemid 28409250)
61. American Academy of Pediatrics. Committee on Infectious Disease, Policy statement-modified recommendations for use of palivizumab for prevention of respiratorysyncytial virus infections. Pediatrics 2009 124 6 1694 1701
62. Raccomandazioni della società italiana di neonatologia per la prevenzione delle malattie da virus respiratorio sinciziale (VRS). Acta Neonatologica e Pediatrica 2004 18 19 30
63. Grupo de trabajo de la Guía de Práctica Clínica sobre la Bronquiolitis Aguda, Guía de práctica clínica sobre la bronquiolitis aguda. Guías de Práctica Clínica en el SNS 2010 AATRM Núm. 2007/05 Plan de Calidad para el Sistema Nacional de Salud (SNS) del Ministerio de Sanidad y Política Social
64. Joint statement with the Fetus and Newborn Committee, Palivizumab and respiratory syncytial virus immune globulin intravenous for the prophylaxis of respiratory syncytial virus infection in high risk infants. Paediatrics and Child Health 1999 4 7 474 489
65. BC Guidelines for RSV Infection Immunoprophylaxis 2012-13 RSV Season, http://www.childhealthbc.ca/
66. Canadian Pediatric Society Statement Palivizumab and respiratory syncytial virus immune globulin intravenous for the prophylaxis of respiratory syncytial virus infection in high risk infants. Paediatrics and Child Health 1999 4 7
67. Mori M., Kawashima H., Nakamura H., Nakagawa M., Kusuda S., Saji T., Tsutsumi H., Yokota S., Itoh S., Nationwide survey of severe respiratory syncytial virus infection in children who do not meet indications for palivizumab in Japan. Journal of Infection and Chemotherapy 2011 17 2 254 263 10.1007/s10156-010-0121-1 2-s2.0-79955888410
68. Manzoni P., Leonessa M., Farina D., Gomirato G., Respiratory syncytial virus infection and prophylaxis with palivizumab in immunosuppressed children: the experience of a large Italian neonatal care setting. Pediatric Transplantation 2007 11 4 456 457 10.1111/j.1399-3046.2006.00672.x 2-s2.0-34247624726 (Pubitemid 46669063)